ArcBlock
Market Open
15 Jun, 08:00
$
0. 212000
-0.002
-0.9346%
$
18,768 Volume
$ 0.214
Previous Close Want to track ABTUSD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abbott Laboratories (ABT) Stock Falls 4.3% After Q1 Earnings Despite Revenue Beat
Shares of Abbott Laboratories (ABT) tumbled in pre-market hours despite delivering robust first-quarter revenue figures and maintaining steady earnings. The healthcare giant's decision to lower its full-year profit outlook coupled with deteriorating operating margins spooked investors, raising red flags about the company's ability to maintain profitability.
Blockonomi | 1 month ago
Abbott Laboratories (ABT) Q1 2026 Results: Revenue Surpasses Expectations on Cancer Diagnostics Strength
Abbott Laboratories delivered first-quarter financial results on April 16 that exceeded Wall Street's revenue projections, with its recently completed cancer diagnostics acquisition providing additional momentum.
Blockonomi | 1 month ago
